NCT03960034
- Conditions
- Atrophy, Body Weight, Body Weight Changes, +21 more
- Locations
-
- Instituto do Câncer do Estado de São Paulo São Paulo, Brazil
Clinical trial condition
NSCLC Stage IV
Explore clinical trials studying NSCLC Stage IV. Study availability and eligibility vary by location and protocol.
54 public trials
21 recruiting studies
NSCLC Stage IV trial results
NCT04633564
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Grodno Clinical Regional Hospital Grodno, Hrodzenskaya Voblasts, Belarus
- Mogilev Regional Oncology Dispensary Minsk, Minsk Oblast, Belarus
- Babruysk Interregional Oncological Dispensary Babruysk, Belarus
- State Institution NN Alexandrov Republican Scientific and Practical Centre of Oncology And Medical R Minsk, Belarus
NCT04076228
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Kiang Wu Hospital Macao, China
NCT03363139
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Complejo Hospitalario Universitario de Santiago Santiago de Compostela, A Coruña, Spain
- Hospital Virgen de los Lirios Alcoy, Alicante, Spain
- Hospital General Universitario de Elche Elche, Alicante, Spain
- Complejo Hospitalario Universitario Insular de Gran Canaria Las Palmas de Gran Canaria, Gran Canaria, Spain
NCT03515252
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +16 more
- Locations
-
Not specified
Active, Not Recruiting
Plasma-Adapted First-Line Pembro In NSCLC
NCT04166487
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Boston Medical Center Boston, Massachusetts, United States
- Dana-Farber at Steward St. Elizabeth's Medical Center Brighton, Massachusetts, United States
Active, Not Recruiting
Immunotherapy Consolidation After Radical Treatment of Synchronous Oligo-metastatic NSCLC
NCT06219317
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Cliniques Universitaires Saint-Luc Brussels, Belgium
- CHU Helora Pole Hospitalier Jolimont Haine-Saint-Paul, Belgium
- CHU Mont Godinne - UCL Namur Yvoir, Belgium
- CH de La Cote Basque - Saint Leon Bayonne, France
Active, Not Recruiting
Adagrasib in Patients With KRASG12C-mutant NSCLC Who Are Elderly or Have Poor Performance Status
NCT05673187
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
- Instiute Jules Bordet Brussels, Belgium
- Le Mans - CHG Le Mans, France
- Hôpital de Marseille Marseille, France
- Beaumont Hospital Dublin, Ireland
Active, Not Recruiting
Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung
NCT03808662
- Conditions
- Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +19 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
- Memorial Sloan Kettering Commack Commack, New York, United States
Active, Not Recruiting
Clinical Utility of Liquid Biopsy in Brigatinib ALK+ Patients
NCT04223596
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
- Locations
-
- Complejo Hospitalario de A Coruña A Coruña, Spain
- Hospital General de Alicante Alicante, Spain
- Hospital Regional Universitario de Málaga Málaga, Andalusia, Spain
- Hospital Son Espases Palma de Mallorca, Balearic Islands, Spain